And in some cases standard treatments with Lupron (leuprolide) or Zoladex (goserelin) is commonly not readily available and/or much too pricey. Lately formulated ADT treatments for example abiraterone and enzalutamide are totally out of access economically for many African individuals and often not out there at all in very low- and reduce-Center-ea